Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Artivion to Participate in Upcoming Investor Conferences
-
Pega to Present at Upcoming Investor Conferences
-
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
JFrog to Present at Upcoming Investor Conferences
-
Ameresco to Participate at Upcoming Conferences
-
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
-
Advantage Solutions to Participate in The Canaccord Annual Growth Conference on August 12, 2025
-
Etsy (ETSY) PT Raised to $76 at Canaccord Genuity
-
Metallic Minerals closes C$6 million private placement financing
-
CORRECTION FROM SOURCE: Metallic Minerals Closes C$6 Million Brokered Private Placement Financing
-
Form 8.3 - [MARLOWE PLC - 29 07 2025] - (CGWL)
-
Metallic Minerals completes C$6 million private placement financing
-
Metallic Minerals Closes C$6 Million Brokered Private Placement Financing
-
BARK Announces Participation in Canaccord Genuity’s 45th Annual Growth Conference on August 12, 2025
-
Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Marker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
-
Dragonfly Energy prices $5.5 million stock offering at $0.25 per share
-
Upexi to Participate in Fireside Chat at Canaccord Genuity’s 45th Annual Growth Conference on August 12th-14th
-
Dragonfly Energy Announces Pricing of $5.5 Million Public Offering of Common Stock
-
Penumbra (PEN) PT Raised to $350 at Canaccord Genuity
-
ArthroCare (ARTC) PT Raised to $53 at Canaccord Genuity
-
NuScale Power to Participate in Upcoming Investor Conferences
-
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
-
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
-
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
-
TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Dragonfly Energy announces public offering of stock and warrants
-
Dragonfly Energy Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference
-
Form 8.3 - [MARLOWE PLC - 28 07 2025] - (CGWL)
-
Faraday Copper Announces Closing of C$49 Million Financing
-
TMX Group CFO David Arnold to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Hudson Technologies to Attend 45th Annual Canaccord Genuity Growth Conference
-
Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference
-
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Dave to Participate in Upcoming Investor Conferences in August
-
AirJoule Technologies Announces Participation in Upcoming Investor Conferences
-
CMG to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
SunPower To Attend Canaccord’s Annual Growth Conference August 12th in Boston
-
CervoMed (CRVO) PT Raised to $27 at Canaccord Genuity
-
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
-
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
Canaccord Genuity Starts Botanix Pharmaceuticals Ltd (BOT:AU) at Buy
-
Interim Management Statement Q3 2025
-
Form 8.3 - [MARLOWE PLC - 25 07 2025] - (CGWL)
-
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference

